The Braster System offers * Prospective observational studies on a group of 1340 women conducted in reference centers for breast cancer diagnostics in Poland from 2009–2016. The Braster medical device was created in cooperation with Polish specialists from the best research centers. Thanks to their knowledge of, among other things, liquid crystal technologies, optoelectronics, and artificial intelligence, we were able to create a system that has the potential to become an important tool in breast cancer prophylaxis for women around the world. Together, we also conducted successful observational studies*. * Observational studies conducted in Poland on a group of over 1500 women from 2013–2016. Braster holds TUV NORD certificates in quality management systems, the main advantages of which are improvement of quality and services and a reduced risk of complaints. The Braster System is a medical product meeting the requirements of the Council Directive 93/42/EEC (CE marking). Saska Kepa Medical Center ul. Marokanska 16, 03-977 (ThermaMED and Innomed) Magodent ul. Fieldorfa 40, 01-999 (ThermaMED) Lower Silesian Center of Oncology pl. Hirszfelda 16, 53-416 (ThermaALG, ThermaMED and Innomed) Femina Medical Center ul. Kłodnicka 23, 40-703 (ThermaMED) Specialist Medical Center for Minimally Invasive Surgery SCM Sp. z o.o. ul. Grzegorzecka 67c/U6, 31-559 (ThermaALG) Independent Public Health Care Center University Hospital (Collegium Medicum Jagiellonian University) ul. Kopernika 36, 31-501 Zdrowie Kobiety Sp. z o.o. ul. Praska 30 C, 30-328 (ThermaALG) * The likelihood of obtaining a positive result of the diagnostic test among ill patients. Higher sensitivity = overlooking fewer ill patients. ** The likelihood of obtaining a negative result of the diagnostic test among patients not suffering from the diagnosed disease. Higher specificity = fewer healthy patients incorrectly identified as ill. "The key to reducing the breast cancer risk is prophylaxis, prophylaxis, and once more prophylaxis." "On the basis of over 1000 examined women, we can certainly conclude that contact thermography is efficient in detecting neoplastic lesions."Efficacy
Learn more
proven
in observational studies*
a chance for detecting alarming
changes at a very early stage,
which means:
Efficacy proven in observational studies
Research centers cooperating with the Braster company
Key conclusions from the ThermaALG observational study:
Expert opinion on
the Braster medical device
8 experts in oncology, radiology, thermography, and optoelectronics with close links to BRASTER
Sign In
Create New Account